Literature DB >> 24035328

Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.

Klaudia U Hunter1, Laura L Fernandes, Karen A Vineberg, Daniel McShan, Alan E Antonuk, Craig Cornwall, Mary Feng, Mathew J Schipper, James M Balter, Avraham Eisbruch.   

Abstract

PURPOSE: Doses actually delivered to the parotid glands during radiation therapy often exceed planned doses. We hypothesized that the delivered doses correlate better with parotid salivary output than the planned doses, used in all previous studies, and that determining these correlations will help make decisions regarding adaptive radiation therapy (ART) aimed at reducing the delivered doses. METHODS AND MATERIALS: In this prospective study, oropharyngeal cancer patients treated definitively with chemoirradiation underwent daily cone-beam computed tomography (CBCT) with clinical setup alignment based on the C2 posterior edge. Parotid glands in the CBCTs were aligned by deformable registration to calculate cumulative delivered doses. Stimulated salivary flow rates were measured separately from each parotid gland pretherapy and periodically posttherapy.
RESULTS: Thirty-six parotid glands of 18 patients were analyzed. Average mean planned doses was 32 Gy, and differences from planned to delivered mean gland doses were -4.9 to +8.4 Gy, median difference +2.2 Gy in glands in which delivered doses increased relative to planned. Both planned and delivered mean doses were significantly correlated with posttreatment salivary outputs at almost all posttherapy time points, without statistically significant differences in the correlations. Large dispersions (on average, SD 3.6 Gy) characterized the dose-effect relationships for both. The differences between the cumulative delivered doses and planned doses were evident at first fraction (r=.92, P<.0001) because of complex setup deviations (eg, rotations and neck articulations), uncorrected by the translational clinical alignments.
CONCLUSIONS: After daily translational setup corrections, differences between planned and delivered doses in most glands were small relative to the SDs of the dose-saliva data, suggesting that ART is not likely to gain measurable salivary output improvement in most cases. These differences were observed at first treatment, indicating potential benefit for more complex setup corrections or adaptive interventions in the minority of patients with large deviations detected early by CBCT.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24035328      PMCID: PMC3805710          DOI: 10.1016/j.ijrobp.2013.07.040

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

2.  Long-term parotid gland function after radiotherapy.

Authors:  Pètra M Braam; Judith M Roesink; Marinus A Moerland; Cornelis P J Raaijmakers; Maria Schipper; Chris H J Terhaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

3.  Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table.

Authors:  Jürgen Meyer; Jürgen Wilbert; Kurt Baier; Matthias Guckenberger; Anne Richter; Otto Sauer; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-15       Impact factor: 7.038

4.  Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy.

Authors:  James L Robar; Allan Day; James Clancey; Robin Kelly; Mammo Yewondwossen; Helmut Hollenhorst; Murali Rajaraman; Derek Wilke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-29       Impact factor: 7.038

5.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.

Authors:  Eric K Hansen; M Kara Bucci; Jeanne M Quivey; Vivian Weinberg; Ping Xia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-26       Impact factor: 7.038

6.  Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.

Authors:  A Eisbruch; H M Kim; J E Terrell; L H Marsh; L A Dawson; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

7.  Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer.

Authors:  Tamaki Nishi; Yasumasa Nishimura; Toru Shibata; Masaya Tamura; Naohiro Nishigaito; Masahiko Okumura
Journal:  Radiother Oncol       Date:  2013-01-19       Impact factor: 6.280

8.  Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.

Authors:  Judith M Roesink; Marinus A Moerland; Anne Hoekstra; Peter P Van Rijk; Chris H J Terhaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-04-01       Impact factor: 7.038

9.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.

Authors:  Jerry L Barker; Adam S Garden; K Kian Ang; Jennifer C O'Daniel; He Wang; Laurence E Court; William H Morrison; David I Rosenthal; K S Clifford Chao; Susan L Tucker; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

10.  Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?

Authors:  Jennifer C O'Daniel; Adam S Garden; David L Schwartz; He Wang; Kian K Ang; Anesa Ahamad; David I Rosenthal; William H Morrison; Joshua A Asper; Lifei Zhang; Shih-Ming Tung; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

View more
  24 in total

1.  Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration.

Authors:  Molly M McCulloch; Guillaume Cazoulat; Alexandra C Ford; Baher Elgohari; Houda Bahig; Andrew D Kim; Hesham Elhalawani; Renjie He; Jihong Wang; Yao Ding; Abdallah Sr Mohamed; Daniel F Polan; Jason B King; Christine B Peterson; Andrea N Ohrt; Clifton D Fuller; Stephen Y Lai; Kristy K Brock
Journal:  Phys Med Biol       Date:  2020-08-31       Impact factor: 3.609

Review 2.  Adaptive radiation therapy in head and neck cancer for clinical practice: state of the art and practical challenges.

Authors:  Ovidiu Veresezan; Idriss Troussier; Alexis Lacout; Sarah Kreps; Sophie Maillard; Aude Toulemonde; Pierre-Yves Marcy; Florence Huguet; Juliette Thariat
Journal:  Jpn J Radiol       Date:  2016-12-01       Impact factor: 2.374

3.  An evaluation of techniques for dose calculation on cone beam computed tomography.

Authors:  Valentina Giacometti; Raymond B King; Christina E Agnew; Denise M Irvine; Suneil Jain; Alan R Hounsell; Conor K McGarry
Journal:  Br J Radiol       Date:  2019-02-26       Impact factor: 3.039

4.  Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.

Authors:  Jolien Heukelom; Michael E Kantor; Abdallah S R Mohamed; Hesham Elhalawani; Esengul Kocak-Uzel; Timothy Lin; Jinzhong Yang; Michalis Aristophanous; Coen R Rasch; Clifton David Fuller; Jan-Jakob Sonke
Journal:  Radiother Oncol       Date:  2019-08-17       Impact factor: 6.280

5.  Future of Radiotherapy in Nasopharyngeal Carcinoma.

Authors:  Xue-Song Sun; Xiao-Yun Li; Qiu-Yan Chen; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Br J Radiol       Date:  2019-07-09       Impact factor: 3.039

6.  Retrospective Clinical Evaluation of a Decision-Support Software for Adaptive Radiotherapy of Head and Neck Cancer Patients.

Authors:  Sebastien A A Gros; Anand P Santhanam; Alec M Block; Bahman Emami; Brian H Lee; Cara Joyce
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

7.  Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer.

Authors:  Molly M McCulloch; Choonik Lee; Benjamin S Rosen; Justin D Kamp; Chrissy M Lockhart; Jae Y Lee; Daniel F Polan; Peter G Hawkins; Carlos J R Anderson; Jolien Heukelom; Jan-Jakob Sonke; Clifton D Fuller; James M Balter; Randall K Ten Haken; Avraham Eisbruch; Kristy K Brock
Journal:  Pract Radiat Oncol       Date:  2019-03-02

8.  Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation.

Authors:  Stuart E Samuels; Yebin Tao; Teresa Lyden; Marc Haxer; Matthew Spector; Kelly M Malloy; Mark E Prince; Carol R Bradford; Francis P Worden; Matthew Schipper; Avraham Eisbruch
Journal:  Oral Oncol       Date:  2016-01-06       Impact factor: 5.337

9.  CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approaches.

Authors:  Simon Wagenblast; Severin Kampfer; Kai J Borm; Stephanie E Combs; Steffi U Pigorsch; Marciana-Nona Duma
Journal:  Strahlenther Onkol       Date:  2018-12-06       Impact factor: 3.621

10.  Predictive dose accumulation for HN adaptive radiotherapy.

Authors:  Donghoon Lee; Pengpeng Zhang; Saad Nadeem; Sadegh Alam; Jue Jiang; Amanda Caringi; Natasha Allgood; Michalis Aristophanous; James Mechalakos; Yu-Chi Hu
Journal:  Phys Med Biol       Date:  2020-11-27       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.